BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/19/2017 11:16:00 AM | Browse: 1567 | Download: 2978
 |
Received |
|
2016-09-15 09:32 |
|
Peer-Review Started |
|
2016-09-15 22:01 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-10-13 17:26 |
|
Revised |
|
2016-10-26 18:41 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-11-11 14:39 |
|
Second Decision by Editor-in-Chief |
|
2016-11-11 23:49 |
|
Final Decision by Editorial Office Director |
|
2016-11-16 16:36 |
|
Articles in Press |
|
2016-11-16 16:36 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-12-28 20:26 |
|
Publish the Manuscript Online |
|
2017-01-19 11:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kouichi Sakurai, Hiroko Suda, Yumi Ido, Takayuki Takeichi, Ayako Okuda, Kiwamu Hasuda and Masahiro Hattori |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kouichi Sakurai, MD, Hattori Clinic, Kumamoto, 2-12-35 Shin-machi, Chuo-ku, Kumamoto 860-0004, Japan. sakuraiko@jcom.zaq.ne.jp
|
| Key Words |
Helicobacter pylori; Eradication treatment; Vonoprazan; Proton pump inhibitors; Adverse event; Smoking |
| Core Tip |
Because the Helicobacter pylori (H. pylori) eradication rate of conventional proton pump inhibi-tor (PPI)-based treatment has decreased because clarithromycin-resistant strains have appeared in recent years, a new treatment strategy is required. Vonoprazan is a novel potassium -competitive acid blocker that has strong, long-lasting effects, but few studies have investigated its efficacy against H. pylori. We compared vonoprazan-based therapy and PPI-based therapy as first-line and second-line treatments. Vonoprazan-based therapy was superior to PPI-based therapy, particularly for smokers, but adverse events (AEs) due to vonoprazan occurred more frequently. Vonoprazan-based therapy is a potentially efficacious treatment, but it should be used with caution due to possible AEs.
|
| Publish Date |
2017-01-19 11:16 |
| Citation |
Sakurai K, Suda H, Ido Y, Takeichi T, Okuda A, Hasuda K, Hattori M. Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy. World J Gastroenterol 2017; 23(4): 668-675 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i4/668.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i4.668 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
